Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
Virginia A. Fonner, Kathleen Ridgeway, Ariane van der Straten, et al.
AIDS (2023) Vol. 37, Iss. 6, pp. 957-966
Open Access | Times Cited: 24

Showing 24 citing articles:

Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition
Lara Lorenzetti, Nhi Dinh, Ariane van der Straten, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. S2
Open Access | Times Cited: 30
Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment
S. Wilson Cole, Jennifer L. Glick, Nicola B. Campoamor, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e083837-e083837
Open Access | Times Cited: 9
Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review
Sara Seyedroudbari, Fatemeh Ghadimi, G. F. Grady, et al.
AIDS and Behavior (2024) Vol. 28, Iss. 9, pp. 3001-3037
Open Access | Times Cited: 9
Protecting Africa's children from extreme risk: a runway of sustainability for PEPFAR programmes
Lucie Cluver, Gibstar Makangila, Susan D. Hillis, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis
Jessica M. Fogel, Estelle Piwowar-Manning, Amber Moser, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 4
Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San Francisco
Kelvin Moore, Noelle Le Tourneau, J.O. Alvarez, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
PrEP Implementation with Sexual and Gender Minority Youth: a Review on Barriers and Facilitators
Andrew P. Barnett, Justin Unternaher, Nicholas Dimenstein, et al.
Current Pediatrics Reports (2025) Vol. 13, Iss. 1
Closed Access
The global HIV response at a crossroads: protecting gains and advancing sustainability amid funding disruptions
Beatrice Matanje, Ruth Laibon Masha, Gallican N. Rwibasira, et al.
The Lancet HIV (2025)
Closed Access
Multipurpose prevention technologies for the prevention of unintended pregnancy, HIV, and other sexually transmitted infections: regulatory pathways and challenges
L.J. Donaldson, Robin Schaefer, Sarah Alhakimi, et al.
Frontiers in Reproductive Health (2025) Vol. 7
Open Access
Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study
Yunia Mayanja, Ivy Kayesu, Onesmus Kamacooko, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 3
HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review
Wanzirai Makoni, Lara Lorenzetti, Noah Mancuso, et al.
AIDS and Behavior (2024)
Closed Access | Times Cited: 3
Global HIV Incidence Analysis and Implications for Affordability Using Long-Acting Cabotegravir Versus Continuous and Event-Driven Oral Preexposure Prophylaxis
Ishani Sharma, Andrew Hill
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 386-394
Open Access | Times Cited: 6
Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis
Carey Pike, Elzette Rousseau, Linda‐Gail Bekker
Southern African Journal of HIV Medicine (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential
Alexis C. Henderson, Preetam Cholli, Margaret A. Lampe, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 153-167
Open Access | Times Cited: 1
HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence
Godfred Yawson Scott, Dominic Worku
Health Science Reports (2024) Vol. 7, Iss. 9
Open Access | Times Cited: 1
HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion Safety
J LEBLANC, Brian Custer, Thijs van de Laar, et al.
Transfusion Medicine Reviews (2023) Vol. 37, Iss. 3, pp. 150754-150754
Closed Access | Times Cited: 3
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy
Angelo Roberto Raccagni, Laura Galli, Maria Francesca Lucente, et al.
AIDS and Behavior (2023) Vol. 28, Iss. 3, pp. 907-911
Closed Access | Times Cited: 3
Biomedical Approaches and Disparities in HIV Prevention
Jared B. Carter-Davis, Ellen C. Seymour
Nursing Clinics of North America (2024) Vol. 59, Iss. 2, pp. 289-296
Closed Access
Low clinical impact of HIV drug resistance mutations in oral pre-exposure prophylaxis: a systematic review and meta-analysis
Brian Eka Rachman, Siti Qamariyah Khairunisa, Citrawati Dyah Kencono Wungu, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response
Katherine B. Rucinski, Jesse Knight, Kalai Willis, et al.
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 4, pp. 208-219
Open Access
Factors driving decisions in the use of HIV pre-exposure prophylaxis: a real-world study in the United States
Y. Omar Whiteside, Abigail McMillan, Fritha Hennessy, et al.
HIV Research & Clinical Practice (2024) Vol. 25, Iss. 1
Open Access
Preferences for Starting Daily, On-Demand, and Long-Acting Injectable HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in the United States (2021-2022): Nationwide Online Cross-Sectional Study
Duygu Işlek, Travis Sanchez, Jennifer L. Glick, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e62801-e62801
Open Access
Updated guidelines on HIV post‐exposure prophylaxis: continued efforts towards increased accessibility
Lao‐Tzu Allan‐Blitz, Kenneth H. Mayer
Journal of the International AIDS Society (2024) Vol. 27, Iss. 11
Open Access
Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs
Jerome Wendoh Milimu, Lauren Parmley, Mahlodi Matjeng, et al.
Frontiers in Reproductive Health (2024) Vol. 6
Open Access
Advancing Long-Acting Formulations for Treating Chronic Diseases
Mohammad Ullah Nayan, Ashrafi Sultana, Nam Thai Hoang Le, et al.
NeuroImmune Pharmacology and Therapeutics (2024), pp. 639-656
Closed Access
Page 1

Scroll to top